Resolute takes on GSK's HIV account
Gemma O'Reilly - 08-Aug-08
Pharma giant GlaxoSmithKline (GSK) has handed the PR support for its main anti-HIV drug to healthcare shop Resolute Communications following a competitive pitch.
Pharma giant GlaxoSmithKline (GSK) has handed the PR support for its main anti-HIV drug to healthcare shop Resolute Communications following a competitive pitch.
To access this article and other content from the PRWeek.com archive, you must be a paid subscriber to PRWeek magazine. As a subscriber you also gain free access to all PRWeek's international titles and online services.
If you have a paid subscription to PRWeek magazine but have not used PRWeek.com before, please click here to activate your subscription